Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
CHAPTERS Group AG: A reportable insider transaction was published on 27th November 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 27th November 2023,
The Insider Transaction was made by Carl, Marlene . The transaction toke place on 24th November 2023. The order was executed at the trading place Xetra. . The aggregated volume was 21.339,00 EUR, based on an average price of 17,70 EUR. The nature of the Investment was Buy.
CHAPTERS Group AG: A reportable insider transaction was published on 27th November 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 27th November 2023,
The Insider Transaction was made by Carl, Marlene . The transaction toke place on 24th November 2023. The order was executed at the trading place Xetra. . The aggregated volume was 21.240,00 EUR, based on an average price of 17,70 EUR. The nature of the Investment was Buy.
CHAPTERS Group AG: A reportable insider transaction was published on 19th April 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 19th April 2023,
The Insider Transaction was made by Mohr, Jan-Hendrik . The transaction toke place on 17th April 2023. The order was executed at the trading place Xetra. . The aggregated volume was 162.594,80 EUR, based on an average price of 15,19 EUR. The nature of the Investment was Buy.
MEDIQON Group AG: A reportable insider transaction was published on 19th April 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 19th April 2023,
The Insider Transaction was made by Mohr, Jan-Hendrik . The transaction toke place on 17th April 2023. The order was executed at the trading place Xetra. . The aggregated volume was 162.594,80 EUR, based on an average price of 15,19 EUR. The nature of the Investment was Buy.
CHAPTERS Group AG: A reportable insider transaction was published on 17th April 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 17th April 2023,
The Insider Transaction was made by Mohr, Jan-Hendrik . The transaction toke place on 14th April 2023. The order was executed at the trading place Xetra. . The aggregated volume was 56.950,00 EUR, based on an average price of 13,96 EUR. The nature of the Investment was Buy.
MEDIQON Group AG: A reportable insider transaction was published on 17th April 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 17th April 2023,
The Insider Transaction was made by Mohr, Jan-Hendrik . The transaction toke place on 14th April 2023. The order was executed at the trading place Xetra. . The aggregated volume was 56.950,00 EUR, based on an average price of 13,96 EUR. The nature of the Investment was Buy.
MEDIQON Group AG: A reportable insider transaction was published on 28th July 2022. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 28th July 2022,
The Insider Transaction was made by Stanza Management Beteiligungen GmbH (vormlas NGC Hamburg GmbH) . The transaction toke place on 26th July 2022. . The aggregated volume was 851.694,00 EUR, based on an average price of 7,60 EUR. The nature of the Investment was not specified.
MEDIQON Group AG: A reportable insider transaction was published on 21st April 2022. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st April 2022,
The Insider Transaction was made by Mohr, Jan-Hendrik . The transaction toke place on 19th April 2022. . The aggregated volume was 236.329,60 EUR, based on an average price of 10,40 EUR. The nature of the Investment was not specified.
MEDIQON Group AG: A reportable insider transaction was published on 21st April 2022. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st April 2022,
The Insider Transaction was made by Carl, Marlene . The transaction toke place on 19th April 2022. . The aggregated volume was 49.961,60 EUR, based on an average price of 10,40 EUR. The nature of the Investment was not specified.
Type | Total | Last | Made by | Go to |
---|---|---|---|---|
Equity Story | 39 | 27th May 2024 | EQS Group AG | EQS |
Corporate Research | 0 | - | - | Corporate Research |
Short Seller (DE) | 0 | - | - | SSR (DE) |
Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.